Ankush Bhatia

Ankush Bhatia practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Ankush Bhatia's NPI, 1225394802, was assigned on April 8, 2012. Ankush Bhatia graduated from Rush Medical College of Rush University in 2012. Ankush Bhatia holds Wisconsin license 75248.

Ankush Bhatia's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Ankush Bhatia's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Ankush Bhatia is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Ankush Bhatia to 1 more hospice, named with a free account. Ankush Bhatia's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Ankush Bhatia practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Ankush Bhatia's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Ankush Bhatia's licenses on file in 2 states: Wisconsin and Texas.

CMS data shows 220 Medicare services from Ankush Bhatia across 3 procedure codes in 2024, for 77 Medicare patients. Medicare paid $14,877 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Ankush Bhatia in 2024. The largest group is 65 to 74, with 41 patients. 52% of them have high blood pressure, and 52% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ankush Bhatia's median patient age at 58, with 47% women.

In 2024, Ankush Bhatia wrote 314 Medicare Part D claims for 66 patients. 90% of them were for generic drugs. CMS names the drug for 223 of them, across 8 drugs with 11 or more claims each, at $67,943 in total drug cost. In 2023, CMS named 190 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Ankush Bhatia for performance year 2024, reported as part of a group. Ankush Bhatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ankush Bhatia as offering telehealth.

Dmand AI links 15 papers to Ankush Bhatia, published from 2011 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Isocitrate Dehydrogenase and Fluorodeoxyglucose F18. Ankush Bhatia has published most often in Clin Cancer Res. Ankush Bhatia's most frequent co-authors are Tejus A. Bale, MD, PhD, Helen H. Chung, MD and Eli Louis Diamond, MD.

Dmand AI links Ankush Bhatia to 4 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Brain Neoplasms.

CMS Open Payments shows 12 general payments to Ankush Bhatia from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 82% of the total. Nuvation Bio Inc. paid the most, $4,999.

Ankush Bhatia graduated from Rush Medical College of Rush University in 2012.